Lower riskMedical device recall · FDA · Published November 29, 2022
Biomet OSS Modular Arthrodesis Nail Recall: Missing Bolts Risk Longer Surgery
Biomet recalls OSS Modular Arthrodesis Nail with missing locking bolts that may require extended surgery to replace. Affected items have specific lot numbers and item codes.
“Biomet OSS Modular Arthrodesis Nail Recall: Missing Bolts Risk Longer Surgery.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/59270-biomet-oss-modular-arthrodesis-nail-recall-missing-bolts-risk-longer. Based on FDA recall #Z-1036-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1036-2023%22&limit=1).
The FDA announced on November 29, 2022, that Biomet, Inc. is recalling the OSS Modular Arthrodesis Nail due to missing locking collar bolts. The hazard may require extension of surgery to find a replacement.
How to tell if you have it
OSS Modular Arthrodesis Nail, 7 Degree Collar Assembly with Locking Bolts-For use in the replacement of segmental defects
UPC: 00880304082991
Lot Number: 136620
The hazard
The product is missing the four small locking collar bolts, which may result in extension of surgery to find a replacement.
Context
GovInfoNow's records show Biomet, Inc. has 28 other recalls on record since February 28, 2018. Other recent recalls include the Biomet Intramedullary Bone Saw Blade Recall (July 1, 2026), the Biomet ZipT recall (September 23, 2025), and the Biomet Juggerknot Mini Soft Anchors Recall (September 9, 2025). Other recent recalls of similar products include the Smith & Nephew TRIGEN Humeral Nail Recall (March 16, 2026), the Zimmer Affixus Antegrade Femoral Nails Recall (December 2, 2025), and the Charlotte Claw Screw Recall (August 18, 2026).
How to tell if you have this one
Check for the item number CP260602 and lot number 136620 on the product packaging. This recall applies to nails sold between 2013 and June 1, 2013.
Look for item number CP260602 and lot number 136620 on the packaging or documentation.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 3 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “US Nationwide distribution in the states of CA, KY, FL.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Florida, Kentucky.
Recall timeline
FDA published this recall 2 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1036-2023 (November 29, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1036-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.